Abstract
This study seeks to determine the cost effectiveness of elective induction of labor at 38 weeks for low-risk nulliparous women compared with expectant management in the setting of the COVID-19 pandemic.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
